Virulence factors and their mechanisms of action: The view from a damage-response framework

Journal of Water and Health

Volumn 7, Issue SUPPL. 1, 2009, Pages

  Casadevall, Arturo ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Damage response framework; Microbe; Pathogen; Pathogenicity; Virulence; Virulence factor

Indexed keywords

ADHESIN; ENZYME; EXOTOXIN; IRON; PROTEIN HISTIDINE KINASE; VIRULENCE FACTOR;

COMMENSAL; HOST-PATHOGEN INTERACTION; INFECTIOUS DISEASE; PATHOGENICITY; VIRULENCE;

APOPTOSIS; BIOFILM; CELL SURVIVAL; COMMENSAL; IMMUNE RESPONSE; NONHUMAN; PATHOGENICITY; REVIEW;

BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; VIRULENCE FACTORS; WATER MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

EID: 77949420600     PISSN: 14778920     EISSN: None     Source Type: Journal    
DOI: 10.2166/wh.2009.036     Document Type: Review

References (115)

1. Ala'Aldeen, D. A. 1996 Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly crossprotective vaccine. J. Med. Microbiol. 44(4), 237-243.
2. Ali, F., Lee, M. E., Iannelli, F., Pozzi, G., Mitchell, T. J., Read, R. C. & Dockrell, D. H. 2003 Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J. Infect. Dis. 188(8), 1119-1131.
3. Angel, C. S., Ruzek, M. & Hostetter, M. K. 1994 Degradation of C3 by Streptococcus pneumoniae. J. Infect. Dis. 170(3), 600-608.
4. Armstrong, D. 1993 History of opportunistic infection in the immunocompromised host. Clin. Infect. Dis. 17(Suppl. 2), S318-S321.
5. Borucki, M. K., Peppin, J. D., White, D., Loge, F. & Call, D. R. 2003 Variation in biofilm formation among strains of Listeria monocytogenes. Appl. Environ. Microbiol. 69(12), 7336-7342.
6. Bronner, S., Monteil, H. & Prevost, G. 2004 Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol. Rev. 28(2), 183-200.
7. Buttner, D. & Bonas, U. 2002 Port of entry-the type III secretion translocon. Trends Microbiol. 10(4), 186-192.
8. Casadevall, A. & Pirofski, L. 1999 Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67, 3703-3713.
9. Casadevall, A. & Pirofski, L. 2000 Host-pathogen interactions: the basic concepts of microbial commensalism, colonization, infection, and disease. Infect. Immun. 68, 6511-6518.
10. Casadevall, A. & Pirofski, L. 2001 Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184, 337-344.
11. Casadevall, A. & Pirofski, L. A. 2002 What is a pathogen? Ann. Med. 34(1), 2-4.
12. Casadevall, A. & Pirofski, L. 2003 The damage-response framework of microbial pathogenesis. Nat. Microbiol. Rev. 1, 17-24.
13. Christie, P. J. 2001 Type IV secretion: intercellular transfer of macromolecules by systems ancestrally related to conjugation machines. Mol. Microbiol. 40(2), 294-305.
14. Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J. & Greenberg, E. P. 2004 Inactivation of a Pseudomonas aeruginosa quorumsensing signal by human airway epithelia. Proc. Natl Acad. Sci. USA 101(10), 3587-3590.
15. Claverys, J. P. 2001 A new family of high-affinity ABC manganese and zinc permeases. Res. Microbiol. 152(3-4), 231-243.
16. Collier, R. J. & Young, J. A. 2003 Anthrax toxin. Ann. Rev. Cell Dev. Biol. 19, 45-70.
17. Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A. & Perfect, J. R. 2000 Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68, 443-448.
18. Cunliffe, J. 2008 A proliferation of pathogens through the 20th century. Scand. J. Immunol. 68(2), 120-128.
19. Cvitkovitch, D. G., Li, Y. H. & Ellen, R. P. 2003 Quorum sensing and biofilm formation in streptococcal infections. J. Clin. Invest. 112(11), 1626-1632.
20. D'Souza, C. A. & Heitman, J. 2001 Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol. Rev. 25(3), 349-364.
21. Danelishvili, L., McGarvey, J., Li, Y. J. & Bermudez, L. E. 2003 Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol. 5(9), 649-660.
22. Deitsch, K. W., Moxon, E. R. & Wellems, T. E. 1997 Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol. Mol. Biol. Rev. 61, 281-293.
23. Dhillon, N. K., Sharma, S. & Khuller, G. K. 2003 Signaling through protein kinases and transcriptional regulators in Candida albicans. Crit. Rev. Microbiol. 29(3), 259-275.
24. Dietrich, C., Heuner, K., Brand, B. C., Hacker, J. & Steinert, M. 2001 Flagellum of Legionella pneumophila positively affects the early phase of infection of eukaryotic host cells. Infect. Immun. 69(4), 2116-2122.
25. Dockrell, D. H., Lee, M., Lynch, D. H. & Read, R. C. 2001 Immunemediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J. Infect. Dis. 184(6), 713-722.
26. Donlan, R. M. 2001 Biofilms and device-associated infections. Emerg. Infect. Dis. 7(2), 277-281.
27. Donlan, R. M. 2002 Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8(9), 881-890.
28. Douglas, L. J. 2003 Candida biofilms and their role in infection. Trends Microbiol. 11(1), 30-36.
29. Dunlop, L. R., Oehlberg, K. A., Reid, J. J., Avci, D. & Rosengard, A. M. 2003 Variola virus immune evasion proteins. Microbes Infect. 5(11), 1049-1056.
30. Falkow, S. 1988 Molecular Koch's Postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2), S274-S276.
31. Falkow, S. 2004 Molecular Koch's postulates applied to bacterial pathogenicity-a personal recollection 15 years later. Nat. Rev. Microbiol. 2(1), 67-72.
32. Fallman, M., Deleuil, F. & McGee, K. 2001 Resistance to phagocytosis by Yersinia. Int. J. Med. Microbiol. 291(6-7), 501-509.
33. Favoreel, H. W., Van De Walle, G. R., Nauwynck, H. J., Mettenleiter, T. C. & Pensaert, M. B. 2003a Pseudorabies virus (PRV)-specific antibodies suppress intracellular viral protein levels in PRV-infected monocytes. J. Gen. Virol. 84(Pt 11), 2969-2973.
34. Favoreel, H.W., van der Walle, G. R., Nauwynck, H. J. & Pensaert, M. B. 2003b Virus complement evasion strategies. J. Gen. Virol. 84(1), 1-15.
35. Gale, C. A., Bendel, C. M., McClellan, M., Hauser, M., Becker, J. M., Berman, J. & Hostetter, M. K. 1998 Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279(5355), 1355-1358.
36. Genco, C. A., Chen, C. Y., Arko, R. J., Kapczynski, D. R. & Morse, S. A. 1991 Isolation and characterization of a mutant of Neisseria gonorrhoeae that is defective in the uptake of iron from transferrin and haemoglobin and is avirulent in mouse subcutaneous chambers. J. Gen. Microbiol. 137(6), 1313-1321.
37. Goldberg, M. B. 2001 Actin-based motility of intracellular microbial pathogens. Microbiol. Mol. Biol. Rev. 65(4), 595-626, (table).
38. Gow, N. A., Brown, A. J. & Odds, F. C. 2002 Fungal morphogenesis and host invasion. Curr. Opin. Microbiol. 5(4), 366-371.
39. Griffin, D. E. & Hardwick, J. M. 1997 Regulators of apoptosis on the road to persistent alphavirus infection. Ann. Rev. Microbiol. 51, 565-592.
40. Gull, K. 2003 Host-parasite interactions and trypanosome morphogenesis: a flagellar pocketful of goodies. Curr. Opin. Microbiol. 6(4), 365-370.
41. Hantke, K. 2001 Iron and metal regulation in bacteria. Curr. Opin. Microbiol. 4(2), 172-177.
42. Henderson, B., Poole, S. & Wilson, M. 1996 Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60, 316-341.
43. Hill, H. R., Bohnsack, J. F., Morris, E. Z., Augustine, N. H., Parker, C. J., Cleary, P. P. & Wu, J. T. 1988 Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J. Immunol. 141(10), 3551-3556.
44. Holbein, B. E. 1980 Iron-controlled infection with Neisseria meningitidis in mice. Infect. Immun. 29(3), 886-891.
45. Houpt, E., Barroso, L., Lockhart, L., Wright, R., Cramer, C., Lyerly, D. & Petri, W. A. 2004 Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine 22(5-6), 612-618.
46. Hoyer, L. L. 2001 The ALS gene family of Candida albicans. Trends Microbiol. 9(4), 176-180.
47. Jarva, H., Jokiranta, T. S., Wurzner, R. & Meri, S. 2003 Complement resistance mechanisms of streptococci. Mol. Immunol. 40(2-4), 95-107.
48. Jawetz, E. 1956 Antimicrobial therapy. Ann. Rev. Microbiol. 10, 85-114.
49. Ji, Y., McLandsborough, L., Kondagunta, A. & Cleary, P. P. 1996 C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64(2), 503-510.
50. Kacani, L., Stoiber, H., Speth, C., Banki, Z., Tenner-Racz, K., Racz, P. & Dierich, M. P. 2001 Complement-dependent control of viral dynamics in pathogenesis of human immunodeficiency virus and simian immunodeficiency virus infection. Mol. Immunol. 38(2-3), 241-247.
51. Keane, J., Balcewicz-Sablinska, M. K., Remold, H. G., Chupp, G. L., Meek, B. B., Fenton, M. J. & Kornfeld, H. 1997 Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65(1), 298-304.
52. Kimbrough, T. G. & Miller, S. I. 2002 Assembly of the type III secretion needle complex of Salmonella typhimurium. Microbe Infect. 4(1), 75-82.
53. Kirov, S. M., Castrisios, M. & Shaw, J. G. 2004 Aeromonas flagella (polar and lateral) are enterocyte adhesins that contribute to biofilm formation on surfaces. Infect. Immun. 72(4), 1939-1945.
54. Kolmer, J. A. 1924 Infection. In: Infection, immunity and biologic therapy. W.B. Saunders Co., Philadelphia, PA. pp. 58-83.
55. Kozel, T. R., Murphy, W. J., Brandt, S., Blazar, B. R., Lovchik, J. A., Thorkildson, P., Percival, A. & Lyons, C. R. 2004 mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl Acad. Sci. USA 101(14), 5042-5047.
56. Kristian, S. A., Golda, T., Ferracin, F., Cramton, S. E., Neumeister, B., Peschel, A., Gotz, F. & Landmann, R. 2004 The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb. Pathog. 36(5), 237-245.
57. Lau, G. W., Ran, H., Kong, F., Hassett, D. J. & Mavrodi, D. 2004 Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect. Immun. 72(7), 4275-4278.
58. Lauter, C. B. 1975 Opportunistic infections. Heart Lung 5, 601-606.
59. Lindahl, G., Sjobring, U. & Johnsson, E. 2000 Human complement regulators: a major target for pathogenic microorganisms. Curr. Opin. Immunol. 12(1), 44-51.
60. Litwin, C. M. & Calderwood, S. B. 1993 Role of iron in regulation of virulence genes. Clin. Microbiol. Rev. 6(2), 137-149.
61. Lyke, K. E., Diallo, D. A., Dicko, A., Kone, A., Coulibaly, D., Guindo, A., Cissoko, Y., Sangare, L., Coulibaly, S., Dakouo, B., Taylor, T. E., Doumbo, O. K. & Plowe, C. V. 2003 Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am. J. Trop. Med. Hyg. 69(3), 253-259.
62. Mattoo, S., Foreman-Wykert, A. K., Cotter, P. A. & Miller, J. F. 2001 Mechanisms of Bordetella pathogenesis. Front. Biosci. 6, E168-E186.
63. Miller, C. P. 1933 Experimental meningococcal infection in mice. Science 78, 340-341.
64. Modun, B., Morrissey, J. & Williams, P. 2000 The staphylococcal transferrin receptor: a glycolytic enzyme with novel functions. Trends Microbiol. 8(5), 231-237.
65. Monack, D. M., Mecsas, J., Ghori, N. & Falkow, S. 1997 Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl Acad. Sci. USA 94(19), 10385-10390.
66. Nagai, H. & Roy, C. R. 2003 Show me the substrates: modulation of host cell function by type IV secretion systems. Cell Microbiol. 5(6), 373-383.
67. Nguyen, D. H. & Hildreth, J. E. 2000 Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74(7), 3264-3272.
68. Nosanchuk, J. D. & Casadevall, A. 2003 The contribution of melanin to microbial pathogenesis. Cell Microbiol. 5(4), 203-223.
69. Nosanchuk, J. D., Ovalle, R. & Casadevall, A. 2001 Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice following systemic infection. J. Infect. Dis. 183, 1093-1099.
70. Noverr, M. C., Williamson, P. R., Fajardo, R. S. & Huffnagle, G. B. 2004 CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 72(3), 1693-1699.
71. Papp-Wallace, K. M. & Maguire, M. E. 2006 Manganese transport and the role of manganese in virulence. Ann. Rev. Microbiol. 60, 187-209.
72. Parsek, M. R. & Singh, P. K. 2003 Bacterial biofilms: an emerging link to disease pathogenesis. Ann. Rev. Microbiol. 57, 677-701.
73. Perkins-Balding, D., Ratliff-Griffin, M. & Stojiljkovic, I. 2004 Iron transport systems in Neisseria meningitidis. Microbiol. Mol. Biol. Rev. 68(1), 154-171.
74. Perry, R. D. 1993 Acquisition and storage of inorganic iron and hemin by the yersiniae. Trends Microbiol. 1(4), 142-147.
75. Pirofski, L. & Casadevall, A. 2002 The meaning of microbial exposure, infection, colonisation, and disease in clinical practice. Lancet Infect. Dis. 2(10), 628.
76. Podbielski, A. & Kreikemeyer, B. 2004 Cell density-dependent regulation: basic principles and effects on the virulence of Gram-positive cocci. Int. J. Infect. Dis. 8(2), 81-95.
77. Poindexter, H. A. & Washington, T. D. 1974 Microbial opportunism in clinical medicine. J. Nat. Med. Assoc. 66, 284-291.
78. Pratt, L. A. & Kolter, R. 1998 Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30(2), 285-293.
79. Ram, S., Mackinnon, F. G., Gulati, S., McQuillen, D. P., Vogel, U., Frosch, M., Elkins, C., Guttormsen, H. K., Wetzler, L. M., Oppermann, M., Pangburn, M. K. & Rice, P. A. 1999 The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36(13-14), 915-928.
80. Ratledge, C. 2004 Iron, mycobacteria and tuberculosis. Tuberculosis (Edin.) 84(1-2), 110-130.
81. Rautemaa, R. & Meri, S. 1999 Complement-resistance mechanisms of bacteria. Microbes Infect. 1(10), 785-794.
82. Remaut, H. & Waksman, G. 2004 Structural biology of bacterial pathogenesis. Curr. Opin. Struct. Biol. 14(2), 161-170.
83. Ritchie, A. J., Yam, A. O., Tanabe, K. M., Rice, S. A. & Cooley, M. A. 2003 Modification of in vivo and in vitro T- and B-cellmediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone. Infect. Immun. 71(8), 4421-4431.
84. Rodriguez, G. M. & Smith, I. 2003 Mechanisms of iron regulation in mycobacteria: role in physiology and virulence. Mol. Microbiol. 47(6), 1485-1494.
85. Rojas, M., Barrera, L. F., Puzo, G. & Garcia, L. F. 1997 Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J. Immunol. 159(3), 1352-1361.
86. Romani, L., Bistoni, F. & Pucetti, P. 2002 Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 10, 508-514.
87. Rosas, A. L., Nosanchuk, J. D. & Casadevall, A. 2001 Passive immunization with melanin-binding monoclonal antibodies prolongs survival in mice with lethal Cryptococcus neoformans infection. Infect. Immun. 69, 3410-3412.
88. Salas, S. D., Bennett, J. E., Kwon-Chung, K. J., Perfect, J. R. & Williamson, P. R. 1996 Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184, 377-386.
89. Sandkvist, M. 2001 Biology of type II secretion. Mol. Microbiol. 40(2), 271-283.
90. Santos, J. L. & Shiozaki, K. 2001 Fungal histidine kinases. Sci. STKE 2001(98), RE1.
91. Schembri, M. A., Dalsgaard, D. & Klemm, P. 2004 Capsule shields the function of short bacterial adhesins. J. Bacteriol. 186(5), 1249-1257.
92. Sibley, L. D. 2003 Toxoplasma gondii: perfecting an intracellular life style. Traffic 4(9), 581-586.
93. Sillanpaa, J., Xu, Y., Nallapareddy, S. R., Murray, B. E. & Hook, M. 2004 A family of putative MSCRAMMs from Enterococcus faecalis. Microbiology 150(Pt 7), 2069-2078.
94. Smith, R. S. & Iglewski, B. H. 2003 Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J. Clin. Invest. 112(10), 1460-1465.
95. Soutourina, O. A. & Bertin, P. N. 2003 Regulation cascade of flagellar expression in Gram-negative bacteria. FEMS Microbiol. Rev. 27(4), 505-523.
96. Staab, J. F., Bradway, S. D., Fidel, P. L. & Sundstrom, P. 1999 Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283(5407), 1535-1538.
97. Stewart, F. S. 1968 Bacteria in health and disease. In Bacteriology and Immunology for Students of Medicine, 9th edition. The Williams & Wilkins Co., Baltimore, pp. 72-91.
98. Tateda, K., Ishii, Y., Horikawa, M., Matsumoto, T., Miyairi, S., Pechere, J. C., Standiford, T. J., Ishiguro, M. & Yamaguchi, K. 2003 The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect. Immun. 71(10), 5785-5793.
99. Tomich, M., Herfst, C. A., Golden, J. W. & Mohr, C. D. 2002 Role of flagella in host cell invasion by Burkholderia cepacia. Infect. Immun. 70(4), 1799-1806.
100. Usher, L. R., Lawson, R. A., Geary, I., Taylor, C. J., Bingle, C. D., Taylor, G. W. & Whyte, M. K. 2002 Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J. Immunol. 168(4), 1861-1868.
101. Vecchiarelli, A. 2000 Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38(6), 407-417.
102. Velasco-Velazquez, M. A., Barrera, D., Gonzalez-Arenas, A., Rosales, C. & Agramonte-Hevia, J. 2003 Macrophage-Mycobacterium tuberculosis interactions: role of complement receptor 3. Microb. Pathog. 35(3), 125-131.
103. von Eiff, C., Peters, G. & Heilmann, C. 2002 Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2(11), 677-685.
104. von Graevenitz, A. 1977 The role of opportunistic bacteria in human disease. Ann. Rev. Microbiol. 31, 447-471.
105. Wann, E. R., Gurusiddappa, S. & Hook, M. 2000 The fibronectinbinding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J. Biol. Chem. 275(18), 13863-13871.
106. Weinberg, E. D. 1999 Iron loading and disease surveillance. Emerg. Infect. Dis. 5(3), 346-352.
107. Weinrauch, Y. & Zychlinsky, A. 1999 The induction of apoptosis by bacterial pathogens. Ann. Rev. Microbiol. 53, 155-187.
108. Wilson, G. S. & Miles, A. 1975 The mechanisms of bacterial invasion. In Topley and Wilson's Principles of Bacteriology, Virology and Immunity, 6th edition. The Williams & Wilkins Co., Baltimore, pp. 1273-1299.
109. Wilson, M., Seymour, R. & Henderson, B. 1998 Bacterial perturbation of cytokine networks. Infect. Immun. 66(6), 2401-2409.
110. Wu, H., Song, Z., Givskov, M. & Hoiby, N. 2004 Effects of quorumsensing on immunoglobulin G responses in a rat model of chronic lung infection with Pseudomonas aeruginosa. Microbe Infect. 6(1), 34-37.
111. Wurzner, R. 1999 Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry. Mol. Immunol. 36(4-5), 249-260.
112. Yarwood, J. M. & Schlievert, P. M. 2003 Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112(11), 1620-1625.
113. Young, G. M., Badger, J. L. & Miller, V. L. 2000 Motility is required to initiate host cell invasion by Yersinia enterocolitica. Infect. Immun. 68(7), 4323-4326.
114. Zhou, D. & Galan, J. 2001 Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbe Infect. 3(14-15), 1293-1298.
115. Zinsser, H. 1914 Infection and the problem of virulence. In Infection and Resistance. The Macmillan Company, NY, pp. 1-27.